Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.42, $0.23 better than the analyst estimate of $2.19. Revenue for the quarter came in at $22.5 billion versus the consensus estimate of $22.17 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.